Acuitas Investments, LLC Kronos Bio, Inc. Transaction History

Acuitas Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$0.92 - $1.5 $102,159 - $166,564	111,043 Added 25.04%	554,500 $554,000
Q2 2024 Aug 05, 2024	BUY	$0.73 - $1.38 $1,716 - $3,244	2,351 Added 0.53%	443,457 $549,000
Q1 2024 May 10, 2024	BUY	$1.02 - $1.3 $115,392 - $147,069	113,130 Added 34.49%	441,106 $573,000
Q4 2023 Feb 02, 2024	SELL	$0.75 - $1.49 $633 - $1,259	-845 Reduced 0.26%	327,976 $409,000
Q3 2023 Oct 27, 2023	SELL	$1.23 - $2.25 $14 - $27	-12 Reduced -0.0%	328,821 $427,000
Q2 2023 Aug 07, 2023	BUY	$1.24 - $1.92 $407,752 - $631,359	328,833 New	328,833 $565,000

20.5M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $57.3M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.